Diabetes.co.in
Dr. Sanjeet Kumar Jaiswal

Dr. Sanjeet Kumar Jaiswal

MBBS, MD (General Medicine), DM (Endocrinologist) (Adult and Pediatric)
Endocrinologist
10 years of experience

Education and Training

DM
King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College, Mumbai, Maharashtra
2016 - 2019
Senior Resident (medicine)
Govt. medical college, Rajnandgaon
2014 - 2016
MD
Pt. Jawahar Lal Nehru Memorial Medical College and Dr. Bhimrao Ambedkar Memorial Hospital, Raipur, Chhattisgarh
2011 - 2014
Kasturba Medical College, Mangaluru
MBBS
Kasturba Medical College, Mangaluru
2005 - 2011

Work Experience

Assistant professor
Department of Endocrinology, King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College, Mumbai, Maharashtra
2025
Consultant Endocrinologist
Ramakrishna CARE Hospitals, Raipur, Chhattisgarh
2025

Clinic Appointment

Ramakrishna CARE Hospitals, Raipur
Dhamtari Road, Raipur, Chhattisgarh, India, 492001
About Dr. Sanjeet Kumar Jaiswal

Academic Experience

  • MD Thesis – Faecal Calprotectin as a Marker of Gut inflammation in Preterm neonates admitted to the Neonatal Intensive Care Unit
  • DM Thesis – Insulin resistance, steatosis and its association with histological activity and fibrosis across genotypes in chronic hepatitis C virus infection

Experience in Clinical trial and Research

  • Genotype- phenotype correlation in Asian Indian  von Hippel–Lindau (VHL)  syndrome patients with  pheochromocytoma/paragan glioma (PPGL) – completed – Familial cancer (international) (2017)
  • Sympathetic paraganglioma:  a single centre experience from western India – Endocrine practice  (international) (2018)
  • Sellar Paraganglioma – Clin Nucl Med (international) (2018)
  • Adrenal gland haemangioma mimicking a  non-functional Pheochromocytoma – Journal of clinical and  diagnostic research  (international) (2018)
  • Adrenal Gland Haemangioma Mimicking a  Non-functional Pheochromocytoma – Journal of Clinical and  Diagnostic Research (2018)
  • Comparison of pheochromocytoma – specific morbidity and mortality among adult with  bilateral pheochromocytoma undergoing total adrenalectomy vs cortical  sparing adrenalectomy  – JAMA ENDOCRINOLOGY (international) (2019)
  • Exendin-4-based imaging in  endogenous hyperinsulinemic hypoglycaemia cohort: A  tertiary Endocrine centre  experience – Clin Endocrinol (Oxf) (2020)
  • 177Lu-DOTATATE therapy in metastatic/inoperable pheochromocytoma paraganglioma – Endocr Connect (2020)
  • The utility of 68Ga DOTATATE PET/CT in  localizing primary/ metastatic pheochromocytoma and  paraganglioma in children  and adolescents – a single center experience - Journal of Pediatric  Endocrinology and  Metabolism (JPEM) (2020)
  • Predictors of chronic LH testosterone axis suppression in male macroprolactinomas with  normoprolactinemia on  cabergoline – Journal of Clinical  Endocrinology and  Metabolism (2020)
  • Familial medullary thyroid  carcinoma: single tertiary  care center experience – Familial cancer (2020)
  • Maternal and Fetal Outcomes in Pheochromocytoma and  Pregnancy: a multi-center  retrospective cohort study  and systematic review of  literature – Lancet (Diabetes and  endocrinology) (2020)

Textbook

Diagnosis and Endoscopic  Endonasal Trans-sphenoid  Surgery of Pituitary Adenoma – Neuroendoscopic Surgery: A Comprehensive Approach (2020)

Oral Presentation

  • International conference: At Japanese endocrinology society (JES) conference at Miyazaki, Japan, April 2020: Sympathetic paraganglioma: a single center experience
  • National conference: Endocrine Society of India (ESI) October 2018: Sympathetic paraganglioma: a single-center experience